Sunesis Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

SNSS 1.42 -0.05 (-3.40%)
price chart
Ahead of the Bell: Sunesis Pharma shares sink
Sunesis said it will seek marketing approval from European regulators and also will meet with the U.S. Food and Drug Administration to determine the "appropriate regulatory path forward.
Sunesis Pharmaceuticals, Inc.'s Flop: More Drugs Out There, Says Roth  Benzinga
Sunesis Announces Results From Pivotal Phase 3 VALOR Trial of Vosaroxin ...  MarketWatch
Related articles »  
Short Interest: JDS Uniphase Corporation (JDSU), Adobe Systems (ADBE ...
Recent short interest data for the 9/30/2014 settlement date shows an increase in short interest for shares of Sunesis Pharmaceuticals, Inc. (SNSS). As of September 30, the short interest for the biopharmaceutical company totaled 10,826,791 shares, ...
Sunesis Pharmaceuticals Inc. (SNSS) Jumps 5.88% on October 17
Sunesis Pharmaceuticals Inc. ($SNSS) was among the biggest gainers on the Russell 2000 for October 17 as the stock popped 5.88% to $1.44, representing a gain of $0.08 per share.
Related articles »  
Hot Stocks Alert: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Sunesis ...
Lakeway, NY - (MARKET NEWS CALL) - 10/22/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Related articles »  
Momentum Stocks: Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), American ...
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) saw a mixed track record, when it comes to anticipates revisions of two increases and one decrease in the previous third trading session.
Related articles »  
Sunesis Pharmaceuticals, Inc. (SNSS): Ken Griffin's Citadel Boosts His Stake
Citadel Advisors, a fund managed by Ken Griffin, has disclosed boosting its stake in Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS).
Investor's Alert: Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), DRDGOLD ...  Techsonian (press release)
Sunesis Pharmaceuticals Sees Unusually High Options Volume (SNSS)  Ticker Report
Related articles »  
Hot Watch List : Verizon Communications Inc. (NYSE:VZ), Sunesis ...
Company weekly performance is 0.23% while its quarterly performance stands at -3.85%. Verizon Communications Inc. (NYSE:VZ) is -8.63% away from its 52 week high.
News Recap: Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), Hemispherx ...  Market News Call
Related articles »  
Sunesis Pharmaceuticals Inc. (SNSS) Hits New 52-week Low During October 10 ...
Sunesis Pharmaceuticals Inc. (SNSS) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $1.22, Sunesis Pharmaceuticals Inc. dropped to $1.05 for a new 52-week low. By the closing bell, the company's ...
Related articles »  
Sunesis Pharmaceuticals Down on Failure of Trial on Qinprezo
Shares of Sunesis Pharmaceuticals, Inc. (SNSS - Snapshot Report) plunged significantly after the company announced that its phase III trial, VALOR, failed to meet its primary endpoint.
Short Interest: Dendreon Corp. (DNDN), Microsoft (MSFT), Endo International ...
Recent short interest data for the 9/30/2014 settlement date shows an increase in short interest for shares of Sunesis Pharmaceuticals, Inc. (SNSS). As of September 30, the short interest for the biopharmaceutical company totaled 10,826,791 shares, ...
Related articles »